Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Memphis, TN
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Arlington, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Dallas, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Houston, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Katy, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Katy, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Kingwood, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Kingwood, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Palestine, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Palestine, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Plano, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
San Antonio, TX
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bountiful, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Murray, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Murray, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Ogden, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Orem, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
South Ogden, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
South Ogden, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
West Jordan, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
West, UT
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
West, UT
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Richmond, VA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Roanoke, VA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Port Orchard, WA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Port Orchard, WA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Charleston, WV
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Charleston, WV
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Kenosha, WI
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Kenosha, WI
Click here to add this to my saved trials
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis (Aim 3)
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis
Status: Enrolling
Updated:  4/7/2016
Emory University
mi
from
Atlanta, GA
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis (Aim 3)
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis
Status: Enrolling
Updated: 4/7/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery
Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?
Status: Enrolling
Updated:  4/11/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery
Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?
Status: Enrolling
Updated: 4/11/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated:  4/15/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated: 4/15/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated:  4/15/2016
Novartis
mi
from
New York, NY
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated: 4/15/2016
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
The Congestive Heart Failure Adherence Redesign Trial
Reduction in Hospitalizations in Low-Income Patients With Heart Failure
Status: Enrolling
Updated:  4/15/2016
Rush University Medical Center
mi
from
Chicago, IL
The Congestive Heart Failure Adherence Redesign Trial
Reduction in Hospitalizations in Low-Income Patients With Heart Failure
Status: Enrolling
Updated: 4/15/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated:  4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated: 4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity
Using Facebook to Increase Social Support for Physical Activity: The INSHAPE Study
Status: Enrolling
Updated:  4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity
Using Facebook to Increase Social Support for Physical Activity: The INSHAPE Study
Status: Enrolling
Updated: 4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status: Enrolling
Updated:  4/20/2016
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research)
mi
from
Baltimore, MD
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status: Enrolling
Updated: 4/20/2016
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated:  4/27/2016
Cooper University Hospital
mi
from
Camden, NJ
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated: 4/27/2016
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated:  4/27/2016
New York-Presbyterian Hospital
mi
from
New York, NY
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated: 4/27/2016
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated:  4/27/2016
Städtische Kliniken Neuss - Lukaskrankenhaus - GmbH
mi
from
Preußenstr. 84,41464 Neuss,
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated: 4/27/2016
Städtische Kliniken Neuss - Lukaskrankenhaus - GmbH
mi
from
Preußenstr. 84,41464 Neuss,
Click here to add this to my saved trials
Myocardial Infarction Genes (MI-GENES) Study
Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack
Status: Enrolling
Updated:  5/2/2016
The Mayo Clinic
mi
from
Rochester, MN
Myocardial Infarction Genes (MI-GENES) Study
Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack
Status: Enrolling
Updated: 5/2/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Ticagrelor vs. Prasugrel Effects on Infarct Size
TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel
Status: Enrolling
Updated:  5/3/2016
Baylor St. Luke's Medical Center
mi
from
Houston, TX
Ticagrelor vs. Prasugrel Effects on Infarct Size
TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel
Status: Enrolling
Updated: 5/3/2016
Baylor St. Luke's Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Ticagrelor vs. Prasugrel Effects on Infarct Size
TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel
Status: Enrolling
Updated:  5/3/2016
Houston Methodist Hospital
mi
from
Houston, TX
Ticagrelor vs. Prasugrel Effects on Infarct Size
TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel
Status: Enrolling
Updated: 5/3/2016
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Ticagrelor vs. Prasugrel Effects on Infarct Size
TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel
Status: Enrolling
Updated:  5/3/2016
Memorial Hermann Hospital
mi
from
Houston, TX
Ticagrelor vs. Prasugrel Effects on Infarct Size
TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel
Status: Enrolling
Updated: 5/3/2016
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Serial Phlebotomy in Voluntary Blood Donors
Serial Phlebotomy in Voluntary Blood Donors
Status: Enrolling
Updated:  5/4/2016
New York University Langone Medical Center
mi
from
New York, NY
Serial Phlebotomy in Voluntary Blood Donors
Serial Phlebotomy in Voluntary Blood Donors
Status: Enrolling
Updated: 5/4/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome
The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome
Status: Enrolling
Updated:  5/5/2016
Columbia University College of Physicians & Surgeons, Morgan Stanley Children's Hospital of New York
mi
from
New York, NY
Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome
The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome
Status: Enrolling
Updated: 5/5/2016
Columbia University College of Physicians & Surgeons, Morgan Stanley Children's Hospital of New York
mi
from
New York, NY
Click here to add this to my saved trials
Physiological Study of Human Cholesterol Metabolism and Excretion
Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated:  5/5/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Physiological Study of Human Cholesterol Metabolism and Excretion
Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated: 5/5/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effects of Health Promoting Programs on Cardiovascular Disease Risk
Effects of Health-Promoting Programs on Cardiovascular Disease Risk: JHS
Status: Enrolling
Updated:  5/10/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Effects of Health Promoting Programs on Cardiovascular Disease Risk
Effects of Health-Promoting Programs on Cardiovascular Disease Risk: JHS
Status: Enrolling
Updated: 5/10/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Mindfulness-Based Stress Reduction and Myocardial Ischemia
Mindfulness-Based Stress Reduction and Myocardial Ischemia
Status: Enrolling
Updated:  5/12/2016
University of Florida
mi
from
Gainesville, FL
Mindfulness-Based Stress Reduction and Myocardial Ischemia
Mindfulness-Based Stress Reduction and Myocardial Ischemia
Status: Enrolling
Updated: 5/12/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients
Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients
Status: Enrolling
Updated:  5/12/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients
Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients
Status: Enrolling
Updated: 5/12/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Birmingham Heart Clinic
mi
from
Birmingham, AL
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Birmingham Heart Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Thomas Hospital
mi
from
Fairhope, AL
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Thomas Hospital
mi
from
Fairhope, AL
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Scottsdale Healthcare
mi
from
Scottsdale, AZ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Arkansas Heart Hospital
mi
from
Little Rock, AR
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
California Cardiovascular Consultants
mi
from
Fremont, CA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
California Cardiovascular Consultants
mi
from
Fremont, CA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
FACT/ Los Angeles Cardiology
mi
from
Los Angeles, CA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
FACT/ Los Angeles Cardiology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
University of Southern California
mi
from
Los Angeles, CA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials